Shares of NASDAQ MRVI opened at $4.20 on Friday. The company has a debt-to-equity ratio of 0.89, a quick ratio of 9.94 and a current ratio of 10.74. The firm has a market cap of $1.06 billion, a ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Based on 5 Wall Street analysts offering 12 month price targets forMaravai LifeSciences Holdings Inc (Class A) - Dist in the last 3 months. Maravai LifeSciences Holdings, Inc., a life sciences company ...
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...
1 Day MRVI 1.94% DJIA -0.37% S&P Mid Cap 400 -0.08% Health Care/Life Sciences -0.69% ...
Maravai LifeSciences enables the development of drug therapies, diagnostics and novel vaccines and supports research on human diseases through its portfolio of market-leading companies and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results